Egyptian study aims to improve eye salvage in retinoblastoma
NCT ID NCT07530458
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will look back at the medical records of 150 children with retinoblastoma who received additional eye treatments after initial chemotherapy. The treatments include radioactive plaque therapy, freezing therapy, or laser therapy. The goal is to see how often each treatment saves the eye and to identify factors that predict success. The study is based at Assiut University in Egypt and has not yet started recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors choose the best consolidation therapy to save more eyes in children with retinoblastoma.
- What could go wrong
- This is a retrospective review, not a controlled trial, so results may be influenced by missing data or selection bias. It only looks at past records and cannot prove which treatment is best.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Targeted radiation zaps childhood brain tumors in early trial
- Newborn screening study aims to catch rare diseases at birth
- Eye-Directed chemotherapy aims to save sight in children with retinoblastoma
- Does anesthesia affect kids' brains? new study investigates
- Chemo plaque could spare Kids' eyes from removal